07141826 1.1.14 31.12.14 31.12.14 Company accounts Private Limited Company FY false true true false false false true true false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure071418262013-12-31071418262014-12-31071418262014-01-012014-12-31071418262012-12-31071418262013-01-012013-12-31071418262013-12-3107141826ns12:England2014-01-012014-12-3107141826ns14:PoundSterling2014-01-012014-12-3107141826ns7:Director12014-01-012014-12-3107141826ns7:OrdinaryShareClass12014-01-012014-12-3107141826ns7:CompanySecretary2014-01-012014-12-3107141826ns7:RegisteredOffice2014-01-012014-12-3107141826ns7:EntityAccountantsOrAuditors2014-01-012014-12-3107141826ns7:EntityAccountantsOrAuditors2014-12-3107141826ns5:BusinessSegment12014-01-012014-12-3107141826ns5:BusinessSegment12013-01-012013-12-3107141826ns5:TotalBusinessSegments2014-01-012014-12-3107141826ns5:TotalBusinessSegments2013-01-012013-12-3107141826ns12:UnitedKingdom2014-01-012014-12-3107141826ns12:UnitedKingdom2013-01-012013-12-3107141826ns12:Europe2014-01-012014-12-3107141826ns12:Europe2013-01-012013-12-3107141826ns12:AllCountries2014-01-012014-12-3107141826ns12:AllCountries2013-01-012013-12-3107141826ns7:Director12013-01-012013-12-3107141826ns7:AllEntityOfficers2014-01-012014-12-3107141826ns7:AllEntityOfficers2013-01-012013-12-3107141826ns7:OrdinaryShareClass12014-12-3107141826ns7:OrdinaryShareClass12013-12-31
REGISTERED NUMBER: 07141826 (England and Wales)















Agora Health Limited

Report of the Director and

Financial Statements for the Year Ended 31 December 2014






Agora Health Limited (Registered number: 07141826)

Contents of the Financial Statements
for the year ended 31 December 2014










Page

Company Information 1

Report of the Director 2

Report of the Independent Auditors 4

Profit and Loss Account 6

Balance Sheet 7

Notes to the Financial Statements 8


Agora Health Limited

Company Information
for the year ended 31 December 2014







DIRECTOR: A J Miller





SECRETARY: Ms H A Hunsperger





REGISTERED OFFICE: Curzon House
24 High Street
Banstead
Surrey
SM7 2LJ





REGISTERED NUMBER: 07141826 (England and Wales)





AUDITORS: Langdon West Williams PLC
Curzon House 2nd Floor
24 High Street
Banstead
Surrey
SM7 2LJ

Agora Health Limited (Registered number: 07141826)

Report of the Director
for the year ended 31 December 2014


The director presents his report with the financial statements of the company for the year ended 31 December 2014.

DIVIDENDS
No dividends will be distributed for the year ended 31 December 2014.

FUTURE DEVELOPMENTS
The company will continue to operate in its existing and directly related markets.

DIRECTOR
A J Miller held office during the whole of the period from 1 January 2014 to the date of this report.

FINANCIAL INSTRUMENTS
Financial risk management
The company's operations expose it to a limited number of financial risks that include the effects of changes in credit
risk, liquidity risk and interest rate risk. Due to the nature of the financial instruments used by the company there is
no exposure to price risk. The company's approach to managing these risks applicable to the financial instruments
concerned is shown below.The company does not make speculative use of derivatives, currency or other instruments.

Credit risk
Credit risk consists mainly of cash deposits and trade debtors.

Cash deposits are all with major banks with high quality credit standing, managed by fellow subsidiaries.

The company has implemented policies that require its subscribers to pay in advance of receiving the relevant product
and if payment is not received within a short predefined time period the subscription is suspended. With regard to
customers to whom credit is permitted, the company has policies regarding the level of credit allowed and the regular
monitoring of amounts outstanding in respect of both time and credit limits.


Liquidity risk
The company's risk to liquidity is a result of the funds available to cover future liabilities and commitments as they fall
due. The company manages liquidity risk through an ongoing reviewing of future liabilities and commitments to
ensure sufficient funds are available to meet amounts due.

Interest rate cash flow risk
The company has only interest bearing assets which comprise only cash balances. It does not have any interest
bearing liabilities. The interest bearing assets are at variable rates through the company's bankers and the company's
policy is to manage interest rate risk so that fluctuations in variable rates do not have a material impact of profit.


Agora Health Limited (Registered number: 07141826)

Report of the Director
for the year ended 31 December 2014

STATEMENT OF DIRECTOR'S RESPONSIBILITIES
The director is responsible for preparing the Report of the Director and the financial statements in accordance with
applicable law and regulations.

Company law requires the director to prepare financial statements for each financial year. Under that law the
director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted
Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the director
must not approve the financial statements unless he is satisfied that they give a true and fair view of the state of
affairs of the company and of the profit or loss of the company for that period. In preparing these financial
statements, the director is required to:

- select suitable accounting policies and then apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company
will continue in business.

The director is responsible for keeping adequate accounting records that are sufficient to show and explain the
company's transactions and disclose with reasonable accuracy at any time the financial position of the company and
enable him to ensure that the financial statements comply with the Companies Act 2006. He is also responsible for
safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of
fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the director is aware, there is no relevant audit information (as defined by Section 418 of the Companies Act
2006) of which the company's auditors are unaware, and he has taken all the steps that he ought to have taken as a
director in order to make himself aware of any relevant audit information and to establish that the company's
auditors are aware of that information.

AUDITORS
The auditors, Langdon West Williams PLC, will be proposed for re-appointment at the forthcoming Annual General
Meeting.

ON BEHALF OF THE BOARD:





A J Miller - Director


28 May 2015

Report of the Independent Auditors to the Members of
Agora Health Limited


We have audited the financial statements of Agora Health Limited for the year ended 31 December 2014 on pages six
to eleven. The financial reporting framework that has been applied in their preparation is applicable law and United
Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the
Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those
matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent
permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's
members as a body, for our audit work, for this report, or for the opinions we have formed.

Respective responsibilities of director and auditors
As explained more fully in the Statement of Director's Responsibilities set out on page three, the director is responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view. Our responsibility is to audit and express an opinion on the financial statements in accordance with applicable law and International Standards on Auditing (UK and Ireland). Those standards require us to comply with the Auditing Practices Board's Ethical Standards for Auditors.

Scope of the audit of the financial statements
An audit involves obtaining evidence about the amounts and disclosures in the financial statements sufficient to give
reasonable assurance that the financial statements are free from material misstatement, whether caused by fraud or
error. This includes an assessment of: whether the accounting policies are appropriate to the company's
circumstances and have been consistently applied and adequately disclosed; the reasonableness of significant
accounting estimates made by the director; and the overall presentation of the financial statements. In addition, we
read all the financial and non-financial information in the Report of the Director to identify material inconsistencies
with the audited financial statements and to identify any information that is apparently materially incorrect based on,
or materially inconsistent with, the knowledge acquired by us in the course of performing the audit. If we become
aware of any apparent material misstatements or inconsistencies we consider the implications for our report.


Opinion on financial statements
In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 31 December 2014 and of its profit for the year
then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Opinion on other matter prescribed by the Companies Act 2006
In our opinion the information given in the Report of the Director for the financial year for which the financial
statements are prepared is consistent with the financial statements.

Report of the Independent Auditors to the Members of
Agora Health Limited


Matters on which we are required to report by exception
We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to
you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from
branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of director's remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit; or
- the director was not entitled to take advantage of the small companies' exemption from the requirement to
prepare a Strategic Report.




Ian Watt (Senior Statutory Auditor)
for and on behalf of Langdon West Williams PLC
Curzon House 2nd Floor
24 High Street
Banstead
Surrey
SM7 2LJ

28 May 2015

Agora Health Limited (Registered number: 07141826)

Profit and Loss Account
for the year ended 31 December 2014

2014 2013
Notes £    £   

TURNOVER 2 1,370,966 1,420,531

Cost of sales 856,305 823,015
GROSS PROFIT 514,661 597,516

Administrative expenses 496,945 395,909
OPERATING PROFIT and
PROFIT ON ORDINARY ACTIVITIES BEFORE
TAXATION

4

17,716

201,607

Tax on profit on ordinary activities 5 3,808 46,866
PROFIT FOR THE FINANCIAL YEAR 13,908 154,741

CONTINUING OPERATIONS
None of the company's activities were acquired or discontinued during the current year or previous year.

TOTAL RECOGNISED GAINS AND LOSSES
The company has no recognised gains or losses other than the profits for the current year or previous year.


Agora Health Limited (Registered number: 07141826)

Balance Sheet
31 December 2014

2014 2013
Notes £    £   
CURRENT ASSETS
Stocks 7 20,219 -
Debtors 8 185,967 217,422
206,186 217,422
CREDITORS
Amounts falling due within one year 9 184,657 209,801
NET CURRENT ASSETS 21,529 7,621
TOTAL ASSETS LESS CURRENT LIABILITIES 21,529 7,621

CAPITAL AND RESERVES
Called up share capital 10 100 100
Profit and loss account 11 21,429 7,521
SHAREHOLDERS' FUNDS 15 21,529 7,621


The financial statements were approved by the director on 28 May 2015 and were signed by:





A J Miller - Director


Agora Health Limited (Registered number: 07141826)

Notes to the Financial Statements
for the year ended 31 December 2014


1. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared in accordance with applicable accounting standards.

The following accounting policies have been applied consistently in dealing with material items in relation to
the financial statements.

Accounting convention
The financial statements have been prepared under the historical cost convention.

Financial reporting standard number 1
Exemption has been taken from preparing a cash flow statement on the grounds that the company qualifies as
a small company.

Turnover
Turnover represents the amount derived from the company's principal activity of publishing and marketing
and after the deduction of refunds and value added tax. Subscription income, after adjusting for refunds, is
recognised as revenue on the basis of the sales value of the publications delivered in relation to the total sales
value of all items covered by the subscription.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and
slow moving items.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the
balance sheet date.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the
balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange
ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating
result.

Deferred promotional expenditure
Promotional expenditure incurred during the year is matched against revenue generated by that expenditure.
Deferred promotional expenditure included in the balance sheet represents expenditure incurred during the
year in respect of which revenue is expected to arise after the balance sheet date.

2. TURNOVER

The turnover and profit before taxation are attributable to the one principal activity of the company.

An analysis of turnover by class of business is given below:

2014 2013
£    £   
Publishing & related products 1,370,966 1,420,531
1,370,966 1,420,531

Agora Health Limited (Registered number: 07141826)

Notes to the Financial Statements - continued
for the year ended 31 December 2014


2. TURNOVER - continued

An analysis of turnover by geographical market is given below:

2014 2013
£    £   
United Kingdom 881,957 860,808
Europe 226,340 276,992
Rest of the World 262,669 282,731
1,370,966 1,420,531

3. STAFF COSTS

There were no staff costs for the year ended 31 December 2014 nor for the year ended 31 December 2013.

4. OPERATING PROFIT

The operating profit is stated after charging:

2014 2013
£    £   
Management charges payable to fellow subsidiary undertakings 467,580 381,366
Management charges payable to group companies 15,581 18,190
Directors remuneration paid by fellow subsidiary undertaking 69,783 49,966

Director's remuneration - -

The number of directors to whom retirement benefits were accruing was as follows:

Money purchase schemes 1 1

The auditors remuneration for the period was nil (2013).

5. TAXATION

Analysis of the tax charge
The tax charge on the profit on ordinary activities for the year was as follows:
2014 2013
£    £   
Current tax:
UK corporation tax 3,808 46,866
Tax on profit on ordinary activities 3,808 46,866

Agora Health Limited (Registered number: 07141826)

Notes to the Financial Statements - continued
for the year ended 31 December 2014


6. DIVIDENDS
2014 2013
£    £   
Ordinary shares of £1 each
Interim - 160,000

7. STOCKS
2014 2013
£    £   
Finished goods 20,219 -

8. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2014 2013
£    £   
Amounts owed by group
undertakings 185,967 217,422
185,967 217,422

9. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2014 2013
£    £   
Trade creditors 74,657 73,217
Accrued expenses - 8,584
Deferred income 110,000 128,000
184,657 209,801

10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2014 2013
value: £    £   
100 Ordinary £1 100 100

11. RESERVES
Profit
and loss
account
£   

At 1 January 2014 7,521
Profit for the year 13,908
At 31 December 2014 21,429


Agora Health Limited (Registered number: 07141826)

Notes to the Financial Statements - continued
for the year ended 31 December 2014


12. ULTIMATE PARENT COMPANY

Agora Inc. (incorporated in United States of America ) is regarded by the director as being the company's
ultimate parent company.

The company's immediate parent undertaking at the balance sheet date was Agora Publishing Limited, a
company incorporated in England and Wales. The accounts are available from 8th Floor Friars Bridge Court,
41-45 Blackfriars Road, London SE1 8NZ.

13. RELATED PARTY DISCLOSURES

The company has been charged management charges totalling £15,581 by Agora Inc., the ultimate parent
company (2013 - £18,190).

The company has been charged £467,570 (2013 - £381,366) by Fleet Street Publications Limited, a fellow
group undertaking, for services and costs incurred on its behalf on normal commercial terms. The amount
owed by fellow group undertakings at the balance sheet date is disclosed within Debtors: Amounts falling due
within one year.

The company has been charged £13,794 (2013 - £14,543) for group database charges by Agora Inc., the
ultimate parent company. At the year end the amount owed to Agora Inc. was nil (2013 - nil).

Advantage has been taken of the exemptions provided in Financial Reporting Standard No 8 not to disclose
related party transaction with the immediate parent undertaking and fellow subsidiary undertakings of that
company.

14. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is W R Bonner.


15. RECONCILIATION OF MOVEMENTS IN SHAREHOLDERS' FUNDS
2014 2013
£    £   
Profit for the financial year 13,908 154,741
Dividends - (160,000 )
Net addition/(reduction) to shareholders' funds 13,908 (5,259 )
Opening shareholders' funds 7,621 12,880
Closing shareholders' funds 21,529 7,621